Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 180.00
-2.10 (-1.15%)
Mar 9, 2026, 5:29 PM CET
Xvivo Perfusion AB Revenue
In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M SEK, down -1.25%. Xvivo Perfusion AB had revenue of 226.14M in the quarter ending December 31, 2025, a decrease of -0.62%.
Revenue
812.17M
Revenue Growth
-1.25%
P/S Ratio
7.06
Revenue / Employee
4.10M
Employees
198
Market Cap
5.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.17M | -10.25M | -1.25% |
| Dec 31, 2024 | 822.42M | 224.87M | 37.63% |
| Dec 31, 2023 | 597.54M | 182.25M | 43.88% |
| Dec 31, 2022 | 415.29M | 156.91M | 60.73% |
| Dec 31, 2021 | 258.39M | 78.53M | 43.66% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MedCap AB | 2.11B |
| CellaVision AB | 748.45M |
| Vitrolife AB | 3.44B |
| Nolato AB | 9.46B |
| Elekta AB | 17.11B |
| BICO Group AB | 1.50B |
| Paxman AB | 323.56M |
| Sedana Medical AB | 200.23M |
Xvivo Perfusion AB News
- 17 days ago - The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors - Accesswire